We're delighted to announce our participation at ISPOR Europe 2024 in Barcelona this November. We'll...
Read moreWe explore whether pharma and biotech manufacturers are ready for the new EU HTA process and what op...
Read moreWe examine whether the joint clinical assessment will expedite patient access and influence value pe...
Read moreOur latest article discusses key strategies for pharma manufacturers' commercial readiness for EU HT...
Read moreThe Spanish Ministry of Health's Draft Royal Decree on HTA reshapes assessments, aligning with EU-H...
Read moreThe collaboration is aimed at enhancing HTA reports, facilitating resource and knowledge sharing and...
Read moreWe summarise the key discussions from HTAi 2024, with a focus on sustainability, networks and innova...
Read moreWe discuss the updates on EU HTA from the June meeting of the Member State Coordination Group on Hea...
Read moreLearn how to navigate the upcoming EU HTA regulation and optimise market access strategies for oncol...
Read moreOur experts analyse how local European markets are integrating the EU HTA outputs into national proc...
Read more